Tiotropium in the Treatment of the Patients With Chronic Obstructive Pulmonary Disease
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To collect post-marketing safety and effectiveness information on the use of Tiotropium
Inhalation Capsules (18 μg) in patients with chronic obstructive pulmonary disease in daily
clinical settings